S1PR1 and neoplasm: In order to investigate the potential contribution of infiltrating T-cells on tumor regression following combination therapy, FTY−720 (a sphingosine 1-phosphate receptor agonist) was used to impair T-cell emigration from lymphoid organs21,22.